Location: Redwood City, CA
CIK: 0001582844 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $149M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TSHA | TAYSHA GENE THERAPIES INC | 3,827,926 | $12.1M | 8.1% | $1.87 | 0.0% | COM SHS | 877619106 |
| APLS | APELLIS PHARMACEUTICALS INC | 244,484 | $9.3M | 6.2% | $44.70 | -1.7% | COM | 03753U106 |
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $8.951M | 6.0% | $27.48 | -78.8% | COM | 00032Q104 |
| — | PRAXIS PRECISION MEDICINES I | 4,485,000 | $7.669M | 5.1% | $1.18 | — | COM | 74006W108 |
| — | RAYZEBIO INC | 344,571 | $7.649M | 5.1% | $22.20 | — | COM | 75525N107 |
| SRPT | SAREPTA THERAPEUTICS INC | 550 | $7.581M | 5.1% | $113.03 | 0.0% | Call | 803607100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 362,000 | $7.417M | 5.0% | $18.54 | -2.0% | COM | 77313F106 |
| VTYX | VENTYX BIOSCIENCES INC | 205,377 | $7.133M | 4.8% | $25.25 | +36.9% | COM | 92332V107 |
| IRON | DISC MEDICINE INC | 138,198 | $6.493M | 4.4% | $35.48 | +41.0% | COM | 254604101 |
| KURA | KURA ONCOLOGY INC. | 702,093 | $6.403M | 4.3% | $14.15 | -28.2% | COM | 50127T109 |
| — | CYMABAY THERAPEUTICS INC | 418,000 | $6.232M | 4.2% | $6.27 | — | COM | 23257D103 |
| PCVX | VAXCYTE INC | 121,022 | $6.17M | 4.1% | $31.29 | +57.6% | COM | 92243G108 |
| IMVT | IMMUNOVANT INC | 129,000 | $4.952M | 3.3% | $18.65 | +21.2% | COM | 45258J102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 297,035 | $4.313M | 2.9% | $19.65 | -3.7% | COM | 87164F105 |
| — | HILLEVAX INC | 270,319 | $3.636M | 2.4% | $14.31 | — | COM | 43157M102 |
| ALKS | ALKERMES PLC | 126,500 | $3.543M | 2.4% | $28.90 | +1.5% | SHS | G01767105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 224,339 | $3.441M | 2.3% | $19.84 | -3.9% | COM | 92790C104 |
| CLDX | CELLDEX THERAPEUTICS INC | 122,341 | $3.367M | 2.3% | $9.46 | +231.3% | COM NEW | 15117B202 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 94,000 | $2.796M | 1.9% | $20.61 | 0.0% | COM | 22663K107 |
| TERN | TERNS PHARMACEUTICALS INC | 555,260 | $2.793M | 1.9% | $5.72 | +11.0% | COM | 880881107 |
| REPL | REPLIMUNE GROUP INC | 150,000 | $2.567M | 1.7% | $19.64 | 0.0% | COM | 76029N106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 300,128 | $2.398M | 1.6% | $10.15 | +8.1% | COM NEW | 30233G209 |
| — | IKENA ONCOLOGY INC | 551,010 | $2.386M | 1.6% | $6.56 | — | COM | 45175G108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 323,349 | $2.092M | 1.4% | $6.47 | — | SPONSORED ADS | 152309100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 153,007 | $1.89M | 1.3% | $7.32 | +39.3% | COM | 68062P106 |
| SRPT | SAREPTA THERAPEUTICS INC | 15,500 | $1.879M | 1.3% | $113.03 | 0.0% | COM | 803607100 |
| VSTM | VERASTEM INC | 230,000 | $1.87M | 1.3% | $6.94 | +38.4% | COM NEW | 92337C203 |
| REPL | REPLIMUNE GROUP INC | 1,000 | $1.766M | 1.2% | $19.64 | 0.0% | Call | 76029N106 |
| — | 89BIO INC | 1,000 | $1.523M | 1.0% | $15.44 | — | Call | 282559103 |
| ELVN | ENLIVEN THERAPEUTICS INC | 103,600 | $1.415M | 0.9% | $20.25 | -16.8% | COM | 29337E102 |
| DYN | DYNE THERAPEUTICS INC | 146,500 | $1.313M | 0.9% | $11.28 | -4.5% | COM | 26818M108 |
| — | KRONOS BIO INC | 718,739 | $934K | 0.6% | $1.48 | — | COM | 50107A104 |
| ACRS | ACLARIS THERAPEUTICS | 121,692 | $834K | 0.6% | $16.22 | -47.3% | COM | 00461U105 |
| — | BRAINSTORM CELL THERAPEUTICS | 2,500 | $825K | 0.6% | — | — | Put | 10501E201 |
| BMEA | BIOMEA FUSION INC | 39,935 | $550K | 0.4% | $31.30 | -42.4% | COM | 09077A106 |
| IONS | IONIS PHARMACEUTICALS INC | 11,300 | $513K | 0.3% | $41.26 | 0.0% | COM | 462222100 |
| — | 89BIO INC | 32,800 | $506K | 0.3% | $15.44 | — | COM | 282559103 |
| CYPH | LEAP THERAPEUTICS INC | 354,166 | $489K | 0.3% | $2.32 | 0.0% | COM NEW | 52187K200 |
| RZLT | REZOLUTE INC | 310,000 | $409K | 0.3% | $3.30 | -50.6% | COM NEW | 76200L309 |
| — | CELLECTAR BIOSCIENCES INC. | 121,300 | $320K | 0.2% | $2.64 | — | COM NEW | 15117F807 |
| GPCR | STRUCTURE THERAPEUTICS INC | 5,000 | $252K | 0.2% | $50.42 | — | SPONSORED ADS | 86366E106 |
| ANTX | AN2 THERAPEUTICS INC | 13,300 | $214K | 0.1% | $11.32 | 0.0% | COM | 037326105 |
| — | MARINUS PHARMECEUTICALS INC | 19,500 | $157K | 0.1% | $8.05 | — | COM NEW | 56854Q200 |
| — | MERSANA THERAPEUTICS INC | 99,607 | $127K | 0.1% | $1.27 | — | COM | 59045L106 |
| — | GLYCOMIMETIC INC | 27,500 | $41,250 | 0.0% | $1.50 | — | COM | 38000Q102 |
| — | NUVATION BIO INC | 90,832 | $9,083 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |